Parkinson's disease

News

Biogen has stopped development of Denali-partnered Parkinson's disease candidate BIIB122, after it failed to move the needle in a phase 2b trial.

News

Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.

News

Novo Nordisk has sold the rights to one of the flagship candidates in its now-defunct cell therapy unit to AI start-up Cellular Intelligence.

News

Researchers have used a machine learning algorithm to try to work out why Parkinson's disease patients can respond so differently to treatment.

News

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.

R&D

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater.